Allstate (NYSE:ALL) Price Target Raised to $225.00

Allstate (NYSE:ALLGet Free Report) had its target price increased by investment analysts at Keefe, Bruyette & Woods from $222.00 to $225.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the insurance provider’s stock. Keefe, Bruyette & Woods’ price target points to a potential upside of 18.08% from the company’s previous close.

Several other analysts have also recently issued reports on the stock. Evercore ISI boosted their price objective on shares of Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a research note on Wednesday, October 9th. UBS Group raised their target price on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research note on Monday. Piper Sandler increased their price target on Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a report on Friday, August 16th. Morgan Stanley raised their target price on Allstate from $202.00 to $215.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Finally, The Goldman Sachs Group boosted their target price on shares of Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $210.31.

Get Our Latest Analysis on ALL

Allstate Stock Up 0.9 %

Shares of NYSE ALL opened at $190.55 on Wednesday. The firm’s 50 day moving average price is $188.89 and its 200 day moving average price is $175.59. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The firm has a market cap of $50.46 billion, a P/E ratio of 12.34, a price-to-earnings-growth ratio of 1.71 and a beta of 0.48. Allstate has a 1 year low of $127.93 and a 1 year high of $198.79.

Allstate (NYSE:ALLGet Free Report) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. During the same period in the prior year, the firm posted $0.81 earnings per share. The business’s quarterly revenue was up 14.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Allstate will post 15.23 earnings per share for the current year.

Insider Activity at Allstate

In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the sale, the executive vice president now directly owns 19,163 shares in the company, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $179.09, for a total value of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 192,530 shares of company stock worth $34,967,665 in the last 90 days. Corporate insiders own 1.80% of the company’s stock.

Institutional Trading of Allstate

Several institutional investors have recently made changes to their positions in ALL. SPC Financial Inc. boosted its stake in shares of Allstate by 3.6% during the 3rd quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock valued at $297,000 after buying an additional 54 shares during the period. Lake Street Advisors Group LLC raised its stake in shares of Allstate by 1.8% during the 3rd quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock worth $596,000 after purchasing an additional 54 shares in the last quarter. Abacus Planning Group Inc. lifted its holdings in shares of Allstate by 2.4% during the 3rd quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider’s stock valued at $458,000 after buying an additional 56 shares during the last quarter. Chicago Partners Investment Group LLC lifted its stake in Allstate by 1.3% in the third quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock valued at $893,000 after acquiring an additional 59 shares during the last quarter. Finally, Carmichael Hill & Associates Inc. boosted its holdings in Allstate by 15.0% in the third quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock worth $87,000 after purchasing an additional 60 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Allstate Company Profile

(Get Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Recommended Stories

Analyst Recommendations for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.